Collegeville, PA, United States of America

Michael P DeMartino

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2015-2023

where 'Filed Patents' based on already Granted Patents

10 patents (USPTO):

Title: The Innovative Contributions of Michael P. DeMartino

Introduction

Michael P. DeMartino, a prolific inventor located in Collegeville, PA, has made significant contributions to the field of pharmaceuticals through his innovative research and development efforts. With a total of 10 patents to his name, his work primarily focuses on advanced therapeutic compounds aimed at treating various debilitating conditions.

Latest Patents

Among his latest inventions, DeMartino has developed novel compounds classified as furin inhibitors. These compounds, according to Formula (I), are designed to treat fibrotic diseases including pulmonary fibrosis, renal fibrosis, liver fibrosis, skin fibrosis, ocular fibrosis, cardiac fibrosis, and a range of other fibrotic conditions. Additionally, these compounds may be effective in addressing furin-mediated conditions such as hypertension, cancer, infectious diseases, genetic disorders like cystic fibrosis, and neurodegenerative disorders.

Another significant patent from DeMartino includes his work with substituted piperidine derivatives, directed towards compounds outlined in Formula IIII. These innovations function as inhibitors of the ATF4 pathway and hold promise for treating serious health issues such as cancer, Alzheimer’s disease, and various diseases associated with activated unfolded protein response pathways. Moreover, his research calls attention to the potential applications of these compounds in critical areas like organ transplantation, cardiovascular disease, and neurodegeneration.

Career Highlights

Michael P. DeMartino currently works with GlaxoSmithKline Intellectual Property Development Limited, where he continues to push the boundaries of pharmaceutical innovation. His expertise and dedication to research have not only led to numerous patents but have also placed him at the forefront of medical advancements.

Collaborations

Throughout his career, DeMartino has collaborated with accomplished professionals, including Huiping Amy Guan and Linda N. Casillas. These partnerships exemplify the collaborative spirit of innovation that drives the development of groundbreaking medical treatments and therapeutic solutions.

Conclusion

Michael P. DeMartino's innovative contributions to pharmaceutical science through his patents highlight his commitment to addressing complex medical challenges. By developing compounds that target critical pathways in various diseases, he continues to pave the way for future advancements in the healthcare industry. His work is a testament to the power of innovation in transforming lives through medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…